v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Operating activities                
Net loss $ (152,594) $ (665) $ (1,298) $ (1,506) $ (154,258) $ (3,914) $ (4,690) $ (3,261)
Adjustments to reconcile net loss to net cash used for operating activities:                
Stock-based compensation 140,192   152   140,403 523 660 840
Changes in operating assets and liabilities:                
Other assets         9,851 0    
Prepaid expenses         (10) (5) 0 43
Accounts payable         521 0    
Accrued expenses         1,231 (88) (861) 701
Net cash used in operating activities         (2,262) (3,484) (4,891) (1,677)
Financing activities                
Business Combination         26 0    
Proceeds from related party loans         9,911 7,059 10,872 1,661
Payments of deferred offering costs         (7,602) (3,574) (5,981) 0
Net cash (used in) provided by financing activities         2,335 3,485 4,891 1,661
Net change in cash and cash equivalents         73 1 0 (16)
Cash and cash equivalents at beginning of period   $ 12   $ 12 12 12 12 28
Cash and cash equivalents at end of period $ 85   $ 13   85 13 $ 12 $ 12
Supplemental disclosure of non-cash financing activities:                
Related party debt settled in preferred stock pursuant to Debt Exchange Agreement         $ 54,236 $ 0